Sanofi Pasteur: the world’s leading vaccine specialist
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, is the largest company in the world devoted entirely to human vaccines.
In 2010, Sanofi Pasteur distributed more than 1 billion doses of vaccines, making it possible to vaccinate more than 500 million people across the globe.
The company offers the broadest range of vaccines, providing protection against 20 diseases:
bacterial diseases: cholera, diphtheria, Haemophilus influenzae type b infections, meningococcal meningitis (serogroups A, C, Y and W-135), pertussis, pneumococcal infections, tetanus, tuberculosis, typhoid fever, viral diseases: chickenpox, hepatitis A, hepatitis B, influenza, Japanese encephalitis, measles, mumps, poliomyelitis, rabies, rubella and yellow fever.
A Global Operation
Sanofi Pasteur has twelve production and/or R&D sites located in Marcy l'Etoile and Val de Reuil, France; in Swiftwater (Pennsylvania), Cambridge and Canton (Massachusetts), Orlando (Florida) and Rockville (Maryland), USA; in Toronto, Canada; in Pilar, Argentina; in Shenzhen, China; in Hyderabad, India and in Chachoengsao, Thailand. Three new facilities under construction in Ocoyoacac, Mexico ; Neuville, France ; and Shenzhen, China.
In Europe, Sanofi Pasteur MSD, a joint venture with Merck & Co., develops and distributes vaccines in 19 countries in Europe: Germany, Austria, Belgium, Denmark, Spain, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Norway, Netherlands, Portugal, United Kingdom, Sweden, Switzerland.